Defendants Move for Summary Judgment in PPA Cases Involving Seizures, Psychosis, and Belated Injuries

SEATTLE - Companies that once manufactured products containing PPA moved for summary judgment claiming that plaintiffs who allegedly suffered psychosis, seizures, and injuries more than three days after ingestion of a PPA-containing product have no general causation evidence to support their claims. In re: Phenlypropanolamine (PPA) Products Liability Litigation, MDL 1407 (W.D. Wash.).

Wyeth's Dec. 30, 2003, motion, which was filed on behalf of all defendants in the federal MDL for PPA-related injury claims, stated that cases are ripe for summary judgment because the court previously entered an order deeming expert testimony on the aforementioned injuries inadmissible.

'As a result …